Literature DB >> 11708489

Functionality of circulating DNA: the hypothesis of genometastasis.

D García-Olmo1, D C García-Olmo.   

Abstract

The detection of free, circulating tumor DNA in the plasma of cancer patients opens up new possibilities for the diagnosis and prognostication of cancer. Whatever might be the mechanism for the presence of such DNA, it is now clear that oncogenes can circulate in the plasma fraction of blood and we can now ask whether this phenomenon has potentially important implications in cancer patients. The results of our experiments, together with previous observations of other authors, have led us to propose the "Hypothesis of Genometastasis", which suggests that metastases might develop as a result of transfection of susceptible cells in distant target organs with dominant oncogenes that circulate in the plasma and are derived from the primary tumor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11708489     DOI: 10.1111/j.1749-6632.2001.tb03895.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

Review 1.  Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.

Authors:  Bert Gold; Milena Cankovic; Larissa V Furtado; Frederick Meier; Christopher D Gocke
Journal:  J Mol Diagn       Date:  2015-05       Impact factor: 5.568

2.  The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells.

Authors:  Futoshi Okada; Masanobu Kobayashi; Hiroki Tanaka; Tokushige Kobayashi; Hiroshi Tazawa; Yoshihito Iuchi; Kunishige Onuma; Masuo Hosokawa; Mary C Dinauer; Nicholas H Hunt
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 3.  Beyond genetics: epigenetic code in chronic kidney disease.

Authors:  Rama S Dwivedi; James G Herman; Timothy A McCaffrey; Dominic S C Raj
Journal:  Kidney Int       Date:  2010-09-29       Impact factor: 10.612

Review 4.  Stance of MRD in Non-Hodgkin's Lymphoma and its upsurge in the novel era of cell-free DNA.

Authors:  S Garg; A Kumar; R Gupta
Journal:  Clin Transl Oncol       Date:  2021-05-15       Impact factor: 3.405

5.  Non-invasive prenatal diagnosis of multiple endocrine neoplasia type 2A using COLD-PCR combined with HRM genotyping analysis from maternal serum.

Authors:  Hada C Macher; Maria A Martinez-Broca; Amalia Rubio-Calvo; Cristina Leon-Garcia; Manuel Conde-Sanchez; Alzenira Costa; Elena Navarro; Juan M Guerrero
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

6.  A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study.

Authors:  Juulia Jylhävä; Leo-Pekka Lyytikäinen; Mika Kähönen; Nina Hutri-Kähönen; Johannes Kettunen; Jorma Viikari; Olli T Raitakari; Terho Lehtimäki; Mikko Hurme
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

7.  Transfer of malignant trait to immortalized human cells following exposure to human cancer serum.

Authors:  Mohamed Abdouh; Shufeng Zhou; Vincenzo Arena; Manuel Arena; Anthoula Lazaris; Ronald Onerheim; Peter Metrakos; Goffredo Orazio Arena
Journal:  J Exp Clin Cancer Res       Date:  2014-09-30

8.  Cell-free DNA promotes malignant transformation in non-tumor cells.

Authors:  Aline Gomes de Souza; Victor Alexandre F Bastos; Patricia Tieme Fujimura; Izabella Cristina C Ferreira; Letícia Ferro Leal; Luciane Sussuchi da Silva; Ana Carolina Laus; Rui Manuel Reis; Mario Machado Martins; Paula Souza Santos; Natássia C Resende Corrêa; Karina Marangoni; Carolina Hassibe Thomé; Leandro Machado Colli; Luiz Ricardo Goulart; Vivian Alonso Goulart
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

Review 9.  Mechanisms of metastasis.

Authors:  Kent W Hunter; Nigel P S Crawford; Jude Alsarraj
Journal:  Breast Cancer Res       Date:  2008       Impact factor: 6.466

Review 10.  Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.

Authors:  Feifei Cheng; Li Su; Cheng Qian
Journal:  Oncotarget       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.